Skip to main content

Ecco i Late-Breaking Clinical Trials di ESC Congress 2023

Redazione By 19 Luglio 2023Agosto 2nd, 2023No Comments
Dai congressiNews

Sono stati resi noti i Late-Breaking Clinical Trials che verranno presentati nel corso delle Hot Line Sessions di ESC Congress 2023, il prossimo Congresso dell’European Society of Cardiology in programma dal 25 al 28 agosto ad Amsterdam. Come sempre la redazione di Cardioinfo sarà presente al Congresso per interviste, news e approfondimenti.

Di seguito la lista degli studi, divisi per giornata congressuale:

Venerdì 25 agosto:
HOT LINE SESSION 1:
  • STEP HFpEF: once-weekly semaglutide in people with HFpEF and obesity
  • NOAH-AFNET 6: Oral anticoagulation in patients with atrial high rate episodes
  • COP-AF: Colchicine for the prevention of perioperative atrial fibrillation after major thoracic surgery
Sabato 26 agosto:
HOT LINE SESSION 2:
  • Qiliqiangxin in patients with heart failure and reduced ejection fraction – the QUEST study
  • BUDAPEST CRT Upgrade: Cardiac resynchronisation therapy upgrade in heart failure with right ventricular pacing – a multicentre, randomised, controlled trial
  • HEART-FID: Ferric Carboxymaltose in Heart Failure with Iron Deficiency
  • Effects of FCM on recurrent HF hospitalizations: an individual participant data meta-analysis
HOT LINE SESSION 3:
  • FIRE trial: Physiology-Guided Complete PCI in Older MI Patients
  • ECLS-SHOCK – venoarterial membrane oxygenation in cardiogenic shock
  • STOPDAPT-3: An Aspirin-Free antithrombotic strategy for percutaneous coronary intervention
Domenica 27 agosto:
HOT LINE SESSION 4:
  • ILUMIEN IV: OCT Versus Angiography
  • OCT-guided or angiography-guided PCI in complex bifurcation lesions. The OCTOBER trial
  • OCTIVUS: OCT- vs. IVUS-Guided PCI
  • OCT vs. IVUS vs. angiography guidance: a real-time updated network meta-analysis
HOT LINE SESSION 5:
  • ATTRibute-CM: acoramidis (AG10) in patients with transthyretin amyloid cardiomyopathy
  • ARREST trial: Expedited transfer to a cardiac arrest center for OHCA
  • ADVENT: Pulsed Field Ablation vs Thermal Ablation (RF/Cryo) for Paroxysmal AF
HOT LINE SESSION 6:
  • MULTISTARS AMI: Multivessel immediate versus staged revascularization in STEMI
  • CASTLE-HTx: Catheter Ablation versus Medical Therapy to Treat Atrial Fibrillation in End-stage Heart Failure
  • The FRAIL-AF randomized controlled trial
Lunedì 28 agosto:
HOT LINE SESSION 7:
  • Extended clopidogrel monotherapy versus DAPT in high-risk patients: the OPT-BIRISK trial
  • ARAMIS – Anakinra versus Placebo in Acute Myocarditis
  • DANPACE II – Reducing atrial pacing in Sinus Node Disease
HOT LINE SESSION 8:
  • RED-CVD: Improving early diagnosis of cardiovascular disease in patients with type 2 diabetes and COPD
  • NITRATE-CIN – Inorganic nitrate to prevent CIN after angiography for ACS
  • DICTATE-AHF: Early Dapagliflozin Initiation in Acute Heart Failure
  • PUSH-AHF: Natriuresis guided therapy in acute heart failure
HOT LINE SESSION 9:
  • RIGHT: Prolongation of anticoagulation after Primary PCI
  • ONCO DVT Study; Optimal duration of anticoagulation therapy for isolated distal deep vein thrombosis in patients with cancer study
  • Prospective Meta-Analysis of SGLT2 Inhibitor Randomized Trials in COVID-19